These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9047247

  • 1. Antitumor activity of paclitaxel against human breast carcinoma xenografts serially transplanted into nude mice.
    Kubota T, Matsuzaki SW, Hoshiya Y, Watanabe M, Kitajima M, Asanuma F, Yamada Y, Koh JI.
    J Surg Oncol; 1997 Feb; 64(2):115-21. PubMed ID: 9047247
    [Abstract] [Full Text] [Related]

  • 2. UCN-01 (7-hydroxystaurosporine) inhibits the growth of human breast cancer xenografts through disruption of signal transduction.
    Koh J, Kubota T, Migita T, Abe S, Hashimoto M, Hosoda Y, Kitajima M.
    Breast Cancer; 2002 Feb; 9(1):50-4. PubMed ID: 12196722
    [Abstract] [Full Text] [Related]

  • 3. Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP).
    Vanhoefer U, Cao S, Harstrick A, Seeber S, Rustum YM.
    Ann Oncol; 1997 Dec; 8(12):1221-8. PubMed ID: 9496387
    [Abstract] [Full Text] [Related]

  • 4. Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance.
    Vredenburg MR, Ojima I, Veith J, Pera P, Kee K, Cabral F, Sharma A, Kanter P, Greco WR, Bernacki RJ.
    J Natl Cancer Inst; 2001 Aug 15; 93(16):1234-45. PubMed ID: 11504769
    [Abstract] [Full Text] [Related]

  • 5. [Antitumor effect of docetaxel against human endometrial tumor cell lines].
    Shakuto S, Noguchi K, Bissery MC.
    Gan To Kagaku Ryoho; 2005 Oct 15; 32(10):1437-42. PubMed ID: 16227744
    [Abstract] [Full Text] [Related]

  • 6. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
    Lee FY, Borzilleri R, Fairchild CR, Kim SH, Long BH, Reventos-Suarez C, Vite GD, Rose WC, Kramer RA.
    Clin Cancer Res; 2001 May 15; 7(5):1429-37. PubMed ID: 11350914
    [Abstract] [Full Text] [Related]

  • 7. ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel.
    Mao J, Song B, Shi Y, Wang B, Fan S, Yu X, Tang J, Li L.
    Int J Biochem Cell Biol; 2013 Jun 15; 45(6):1064-73. PubMed ID: 23500524
    [Abstract] [Full Text] [Related]

  • 8. Establishment of paclitaxel-resistant breast cancer cell line and nude mice models, and underlying multidrug resistance mechanisms in vitro and in vivo.
    Chen SY, Hu SS, Dong Q, Cai JX, Zhang WP, Sun JY, Wang TT, Xie J, He HR, Xing JF, Lu J, Dong YL.
    Asian Pac J Cancer Prev; 2013 Jun 15; 14(10):6135-40. PubMed ID: 24289639
    [Abstract] [Full Text] [Related]

  • 9. No cross-resistance of taxotere and taxol to conventional chemotherapeutic agents against gastric cancers as detected by MTT assay.
    Maeda S, Saikawa Y, Kubota T, Aoki M, Otani Y, Furukawa T, Watanabe M, Kumai K, Kitajima M.
    Anticancer Res; 2003 Jun 15; 23(4):3147-50. PubMed ID: 12926047
    [Abstract] [Full Text] [Related]

  • 10. Antitumor activity and pharmacokinetics of a morpholino-anthracycline derivative (KRN8602) against human breast carcinoma xenografts serially transplanted into nude mice.
    Kubota T, Suto A, Josui K, Ishibiki K, Abe O, Yamada Y, Asanuma F, Kawamura E, Koh J, Shiina E.
    Jpn J Cancer Res; 1990 Aug 15; 81(8):827-33. PubMed ID: 2144515
    [Abstract] [Full Text] [Related]

  • 11. [Establishment of transplantable human colon cancer cell lines, chemosensitivity of colon carcinomas and the serially transplantable strains with MTT assay].
    Kase S, Kubota T, Furukawa T, Yamaguchi H, Takeuchi T, Takahara T, Suto A, Kodaira S, Ishibiki K.
    Gan To Kagaku Ryoho; 1991 Oct 15; 18(13):2247-53. PubMed ID: 1929445
    [Abstract] [Full Text] [Related]

  • 12. Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel.
    Chou TC, Zhang XG, Harris CR, Kuduk SD, Balog A, Savin KA, Bertino JR, Danishefsky SJ.
    Proc Natl Acad Sci U S A; 1998 Dec 22; 95(26):15798-802. PubMed ID: 9861050
    [Abstract] [Full Text] [Related]

  • 13. In vivo antitumor activity of hexamethylmelamine against human breast, stomach and colon carcinoma xenografts.
    Tanino H, Kubota T, Yamada Y, Koh J, Kase S, Furukawa T, Kuo TH, Saikawa Y, Kitajima M, Naito Y.
    Jpn J Cancer Res; 1995 Aug 22; 86(8):770-5. PubMed ID: 7559101
    [Abstract] [Full Text] [Related]

  • 14. Antitumor activity of paclitaxel and epirubicin in human breast carcinoma, R-27.
    Asanuma F, Yamada Y, Kawamura E, Lee K, Kobayashi H, Yamada T, Suzuki T, Kubota T.
    Folia Microbiol (Praha); 1998 Aug 22; 43(5):473-4. PubMed ID: 9821299
    [Abstract] [Full Text] [Related]

  • 15. [Antitumor effect of docetaxel against human esophagus tumor cell lines and tumor xenografts in nude mice].
    Shakuto S, Fujita F, Fujita M.
    Gan To Kagaku Ryoho; 2006 Mar 22; 33(3):337-43. PubMed ID: 16531714
    [Abstract] [Full Text] [Related]

  • 16. Antitumor efficacy of taxane liposomes on a human ovarian tumor xenograft in nude athymic mice.
    Sharma A, Straubinger RM, Ojima I, Bernacki RJ.
    J Pharm Sci; 1995 Dec 22; 84(12):1400-4. PubMed ID: 8748320
    [Abstract] [Full Text] [Related]

  • 17. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.
    Baselga J, Norton L, Albanell J, Kim YM, Mendelsohn J.
    Cancer Res; 1998 Jul 01; 58(13):2825-31. PubMed ID: 9661897
    [Abstract] [Full Text] [Related]

  • 18. Paclitaxel-induced cytotoxicity--the effects of cremophor EL (castor oil) on two human breast cancer cell lines with acquired multidrug resistant phenotype and induced expression of the permeability glycoprotein.
    Fjällskog ML, Frii L, Bergh J.
    Eur J Cancer; 1994 Jul 01; 30A(5):687-90. PubMed ID: 7915908
    [Abstract] [Full Text] [Related]

  • 19. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer.
    Shi YK, Li ZH, Han XQ, Yi JH, Wang ZH, Hou JL, Feng CR, Fang QH, Wang HH, Zhang PF, Wang FS, Shen J, Wang P.
    Cancer Chemother Pharmacol; 2010 Nov 01; 66(6):1131-40. PubMed ID: 20838997
    [Abstract] [Full Text] [Related]

  • 20. Death receptor-dependent and -independent pathways in anticancer drug-induced apoptosis of breast cancer cells.
    Kim R, Tanabe K, Emi M, Uchida Y, Toge T.
    Oncol Rep; 2003 Nov 01; 10(6):1925-30. PubMed ID: 14534720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.